2 Downloads (Pure)


The treatment goal in type 2 diabetes (T2D) is to keep the blood glucose within a target range. In the early stages of diabetes, the treatment may consist entirely of oral antidiabetics (OAD), which may be preferable over injectables for some people. However, previously published systematic reviews found a low OAD adherence and that the adherence differs between different OAD types. These systematic reviews were performed before 2015, and several new OADs have been marketed since then. Thus, a systematic review will be undertaken to review the newest studies on adherence to oral second line antidiabetics in people with T2D.
Original languageEnglish
Title of host publicationProceedings of the 18th Scandinavian Conference on Health Informatics
PublisherLinköping University Electronic Press
Publication dateAug 2022
ISBN (Electronic)978-91-7929-344-4
Publication statusPublished - Aug 2022
EventThe Scandinavian Conference on Health Informatics (SHI) 2022 - Tromsø, Norway
Duration: 22 Aug 202224 Aug 2022


ConferenceThe Scandinavian Conference on Health Informatics (SHI) 2022
SeriesScandinavian conference on health informatics


  • Type 2 diabetes
  • Adherence
  • Oral antidiabetics
  • Systematic review
  • Protocol


Dive into the research topics of 'The Adherence to Oral Second Line Antidiabetic Medication in People with Type 2 Diabetes: A Protocol for a Systematic Review'. Together they form a unique fingerprint.

Cite this